Bringing Accurate and Flexible Prostate Cancer Insights to AUA2025!

MyProstateScore 2.0 (MPS2) is the only biomarker test with a 99% negative predictive value (NPV) for the prediction of Grade Group ≥2 prostate cancer in patients with a previous negative biopsy. Now with the option to collect samples at home, MPS2 provides an enhanced patient experience that fits seamlessly into your workflow.

Come see us at Booth #719 during AUA2025 and discover how a 30-second urine sample offers unparalleled insights to guide your patients through prostate cancer risk assessment.

Schedule a meeting with our team at the event, or connect with us to learn more about MPS2.